[HTML][HTML] Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala, KP Arjunan… - World journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To evaluate the effect of orally administered plecanatide or dolcanatide, analogs of
uroguanylin, on amelioration of colitis in murine models. METHODS: The cyclic guanosine …

[PDF][PDF] Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala, KP Arjunan, S Saykhedkar… - 2015 - pdfs.semanticscholar.org
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal
inflammation in experimental models Page 1 Kunwar Shailubhai, Vaseem Palejwala, Krishna …

[PDF][PDF] Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala, KP Arjunan, S Saykhedkar… - 2015 - researchgate.net
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal
inflammation in experimental models Page 1 Kunwar Shailubhai, Vaseem Palejwala, Krishna …

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala… - World journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Aim To evaluate the effect of orally administered plecanatide or dolcanatide, analogs of
uroguanylin, on amelioration of colitis in murine models. Methods The cyclic guanosine …

[引用][C] Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai - World Journal of Gastrointestinal Pharmacology and …, 2015 - cir.nii.ac.jp
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate
gastrointestinal inflammation in experimental models of murine colitis | CiNii Research CiNii …

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala, KP Arjunan, S Saykhedkar… - 2015 - hero.epa.gov
AIM: To evaluate the effect of orally administered plecanatide or dolcanatide, analogs of
uroguanylin, on amelioration of colitis in murine models. METHODS: The cyclic guanosine …

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.

K Shailubhai, V Palejwala, KP Arjunan… - World Journal of …, 2015 - europepmc.org
Aim To evaluate the effect of orally administered plecanatide or dolcanatide, analogs of
uroguanylin, on amelioration of colitis in murine models. Methods The cyclic guanosine …

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.

K Shailubhai, V Palejwala, KP Arjunan… - World Journal of …, 2015 - europepmc.org
Aim To evaluate the effect of orally administered plecanatide or dolcanatide, analogs of
uroguanylin, on amelioration of colitis in murine models. Methods The cyclic guanosine …

[PDF][PDF] Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis

K Shailubhai, V Palejwala, KP Arjunan, S Saykhedkar… - 2015 - researchgate.net
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal
inflammation in experimental models Page 1 Kunwar Shailubhai, Vaseem Palejwala, Krishna …